Patients with chronic liver disease and COVID-19 (literature review and own data)
نویسندگان
چکیده
The pandemic of the new coronavirus COVID-19 has switched medicine around world on primary fight against this infection. Patients with chronic liver diseases require increased attention doctors during an epidemic, since background exacerbation their disease, not only risk contracting COVID 19 viral infection increases, but also its more severe course. confirmed damage - high biochemical activity. According to some reports, patients a course have increase in ALT levels, decrease number platelets, level albumin, and connection (although all indicators) higher mortality is possible.
منابع مشابه
COVID-19 and the Elderly with Chronic diseases: Narrative Review
This article has no abstract.
متن کاملChronic Granulomatous Disease, Case Report and Review of Literature
Chronic granulomatous disease (CGD) is a rare inherited disorder characterized by inability of phagocytes to generate oxygen radicals needed for intracellular killing of phagocytic microorganisms. We report a 2.5-year-old Iranian female with multiple liver abscesses. She was admitted in surgical ward because of abdominal pain and fever for one month duration that had no response to conventio...
متن کاملThrombotic events in COVID-19 patients: a case series and literature review
Background: Coronavirus disease 2019 (COVID-19) has rapidly emerged as a threatening pandemic. Clinical features of this pandemic involve a wide range of manifestations and are not completely known. Here, we present six cases of thrombotic events in patients with COVID-19. Case presentation: In this case series, we present six patients with confirmed COVID-19, according to real-time polymerase...
متن کاملthe past hospitalization and its association with suicide attempts and ideation in patients with mdd and comparison with bmd (depressed type) group
چکیده ندارد.
Taking Renin-Angiotensin Drugs in Patients with COVID-19: Start, Continue, or Stop; a Literature Review
Considering the pandemic of the COVID-19 disease, the use of various drugs in patients has been investigated. Recently, numerous studies have been done on the effectiveness of drugs which used to treat the underlying disease such as congestive heart failure, hypertension, as well as coronary artery disease in various countries, because the patients with underlying conditions are more likely ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Society and innovations
سال: 2021
ISSN: ['2181-1415']
DOI: https://doi.org/10.47689/2181-1415-vol2-iss2/s-pp498-503